Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
DEI Awards
Innovation Awards
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Subscribe
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
DEI Awards
Innovation Awards
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Center for Medicare and Medicaid Innovation (CMMI)
Regulatory
CMMI proposes new models to lower drug prices in Parts B, D
CMS' Innovation Center has released two new drug pricing models that base rebates on international drug prices, which are significantly lower.
Emma Beavins
Dec 22, 2025 12:00pm
CMMI debuts ACCESS Model to spur use of tech for chronic disease
Dec 1, 2025 5:00pm
Paragon Health previews next health reform priorities
Aug 7, 2025 4:15pm
CMMI eyes weight loss drug coverage as IVF pledge slips: reports
Aug 4, 2025 2:50pm
Payer Roundup—AOC slams CMMI model adding prior auth to Medicare
Jul 31, 2025 4:25pm
Population health vendor hires new CEO, unleashes new AI agents
Jul 10, 2025 6:00am